ZERBATO, BARBARA
ZERBATO, BARBARA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage
2025 Zerbato, B; Brancato, V; Giampà, M; Taverna, G; Monterosso, G; Taglietti, L; Lombardi, S; Fontana, C; La Chimia, M; Barabino, S; Urbanucci, A; La Ferla, B; Scumaci, D; Chiaradonna, F
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy
2025 Zerbato, B; Brancato, V; Giampà, M; Taverna, G; Monterosso, G; Taglietti, L; Lombardi, S; Fontana, C; La Chimia, M; Barabino, S; La Ferla, B; Scumaci, D; Chiaradonna, F
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells
2025 Zerbato, B; Cecchetto, T; Sajnani, K; Chiaradonna, F; Urbanucci, A
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells
2025 Zerbato, B; Brancato, V; Giampà, M; Taverna, G; Monterosso, G; Taglietti, L; Lombardi, S; Fontana, C; La Chimia, M; Barabino, S; La Ferla, B; Scumaci, D; Chiaradonna, F
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells
2025 Zerbato, B; Brancato, V; Giampà, M; Taverna, G; Monterosso, G; Taglietti, L; Lombardi, S; Fontana, C; La Chimia, M; Barabino, S; La Ferla, B; Scumaci, D; Chiaradonna, F
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect
2025 Yang, L; Zerbato, B; Pessina, A; Brambilla, L; Andreani, V; Frey-Jakobs, S; Fliegauf, M; Barbouche, M; Zhang, Q; Chiaradonna, F; Proietti, M; Du, X; Grimbacher, B
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells
2024 Venturi, S; Chiaradonna, F; Gatti, F; La Ferla, B; Parolini, R; Zerbato, B
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage
2024 Zerbato, B; Brancato, V; La Chimia, M; Gobbi, M; Lattuada, C; Pessina, A; Brambilla, L; Wegner, A; Scumaci, D; Chiaradonna, F
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage
2024 Zerbato, B; Brancato, V; Lattuada, C; La Chimia, M; Scumaci, D; Chiaradonna, F
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response
2024 Zerbato, B; Gobbi, M; Ludwig, T; Brancato, V; Pessina, A; Brambilla, L; Wegner, A; Chiaradonna, F
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect
2024 Yang, L; Zerbato, B; Pessina, A; Brambilla, L; Andreani, V; Frey-Jakobs, S; Fliegauf, M; Barbouche, M; Zhang, Q; Chiaradonna, F; Proietti, M; Du, X; Grimbacher, B
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment
2024 Zerbato, B; Brancato, V; Gobbi, M; Lattuada, C; La Chimia, M; Pessina, A; Brambilla, L; Wegner, A; Scumaci, D; Chiaradonna, F
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment
2024 Zerbato, B; Brancato, V; Gobbi, M; Lattuada, C; La Chimia, M; Pessina, A; Brambilla, L; Wegner, A; Scumaci, D; Chiaradonna, F
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer
2024 Zerbato, B; Brancato, V; Gobbi, M; Lattuada, C; La Chimia, M; Pessina, A; Brambilla, L; Wegner, A; Scumaci, D; Chiaradonna, F
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy
2024 Zerbato, B; Brancato, V; Gobbi, M; Pessina, A; Brambilla, L; Wegner, A; Chiaradonna, F
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy
2024 Zerbato, B; Brancato, V; Gobbi, M; Pessina, A; Brambilla, L; Wegner, A; Chiaradonna, F
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy
2024 Zerbato, B; Brancato, V; Gobbi, M; Pessina, A; Brambilla, L; Wegner, A; Chiaradonna, F
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer
2023 Zerbato, B; Brancato, V; Lattuada, C; Mossi, F; Gang, Y; Zhang, T; La Chimia, M; Scumaci, D; Chiaradonna, F
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer.
2023 Zerbato, B; Lattuada, C; Mossi, F; Brancato, V; Gang, Y; Zhang, T; La Chimia, M; Scumaci, D; Chiaradonna, F
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response
2023 Zerbato, B; Gobbi, M; Ludwig, T; Brancato, V; Pessina, A; Brambilla, L; Wegner, A; Chiaradonna, F